Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Beijing Wandong Medical Technology Co., Ltd. (600055.SS)
CNY10.78
+0.17 (+1.60%)
CN SHH Healthcare Medical - Devices
Address
Building 3, Yard 9 100015
Beijing, CN
Beijing, CN
CEO
Jinsong Song
Website
wandong.com.cn
IPO
1997-05-19
ISIN CNE000000PZ1
Description
Beijing Wandong Medical Technology Co., Ltd. focuses on the development, production, and sale of advanced medical diagnostic equipment. Their product lineup includes sophisticated MRI solutions, as well as a broad spectrum of radiological imaging systems. This range of radiological offerings features CT scanners, the CGO series, DR and DRF systems, digital mammography units, and mobile X-ray machines. The company, which was previously named China Resources Wandong Medical Equipment Co., Ltd., was founded in 1955 and maintains its headquarters in Beijing, China.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CNY10.78
+0.17 (+1.60%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
6M
Beta
-0.05
Float Shares
440.98M
Free Float %
62.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.55% | -7.82% | -12.73% | -19.01% | -22.40% | -19.06% | -31.54% | -41.43% | -21.19% | +8.52% | +570.74% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
10.78
DCF (Unlevered)
14.65
+35.9%
DCF (Levered)
13.41
+24.4%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 6 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
7.25
Safe zone
Piotroski F-Score
1 / 9
Weak
MOAT Score
0 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
4 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%-12.1% Q1'26: +8.9% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%-245.5% Q1'26: -145.4% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%-27.7% Q1'26: -59.1% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%-27.7% Q1'26: -6.3% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%-21.3% Q1'26: -5.5% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%-0.2% ★ Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-1.36× Q1'26: -2.74× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
818.22M
est: 835.00M (-2.0%)
|
813.40M
est: 954.00M (-14.7%)
|
883.96M
est: 918.00M (-3.7%)
|
954.53M
est: 1.02B (-6.4%)
|
982.37M
est: 1.05B (-6.3%)
|
1.13B
est: 1.17B (-3.0%)
|
1.16B
est: 1.20B (-4.0%)
|
1.12B
est: 1.41B (-20.3%)
|
1.24B
est: 1.67B (-25.9%)
|
1.52B
est: 1.52B (+0.0%)
|
1.34B
est: 1.83B (-26.6%)
|
1.58B
1.58B – 1.58B
-13.6% YoY
|
1.88B
1.88B – 1.88B
+19.2% YoY
|
2.25B
2.25B – 2.25B
+19.9% YoY
|
| EBITDA |
90.79M
est: 129.45M (-29.9%)
|
115.12M
est: 147.90M (-22.2%)
|
155.50M
est: 142.32M (+9.3%)
|
212.89M
est: 158.13M (+34.6%)
|
231.35M
est: 162.62M (+42.3%)
|
305.62M
est: 180.92M (+68.9%)
|
243.70M
est: 186.66M (+30.6%)
|
225.55M
est: 218.13M (+3.4%)
|
248.10M
est: 258.75M (-4.1%)
|
203.03M
est: 309.68M (-34.4%)
|
-321.64M
est: 184.66M (-274.2%)
|
159.47M
159.47M – 159.47M
-13.6% YoY
|
190.05M
190.05M – 190.05M
+19.2% YoY
|
227.79M
227.79M – 227.79M
+19.9% YoY
|
| EBIT |
67.17M
est: 105.93M (-36.6%)
|
83.49M
est: 121.03M (-31.0%)
|
120.23M
est: 116.46M (+3.2%)
|
174.91M
est: 129.40M (+35.2%)
|
192.30M
est: 133.08M (+44.5%)
|
267.09M
est: 148.05M (+80.4%)
|
209.18M
est: 152.75M (+36.9%)
|
194.27M
est: 178.50M (+8.8%)
|
215.03M
est: 211.74M (+1.6%)
|
169.07M
est: 266.75M (-36.6%)
|
-370.76M
est: 132.27M (-380.3%)
|
114.23M
114.23M – 114.23M
-13.6% YoY
|
136.13M
136.13M – 136.13M
+19.2% YoY
|
163.17M
163.17M – 163.17M
+19.9% YoY
|
| Net Income |
40.30M
est: 75.33M (-46.5%)
|
71.54M
est: 105.46M (-32.2%)
|
109.12M
est: 137.10M (-20.4%)
|
153.33M
est: 196.86M (-22.1%)
|
168.88M
est: 235.53M (-28.3%)
|
220.67M
est: 295.29M (-25.3%)
|
183.19M
est: 246.07M (-25.6%)
|
175.37M
est: 288.26M (-39.2%)
|
188.54M
est: 330.44M (-42.9%)
|
157.35M
|
-227.86M
est: 24.54M (-1,028.4%)
|
28.05M
28.05M – 28.05M
+14.3% YoY
|
49.09M
49.09M – 49.09M
+75.0% YoY
|
70.13M
70.13M – 70.13M
+42.9% YoY
|
| SGA |
230.65M
est: 173.14M (+33.2%)
|
261.60M
est: 197.82M (+32.2%)
|
219.77M
est: 190.35M (+15.5%)
|
210.06M
est: 211.50M (-0.7%)
|
207.91M
est: 217.51M (-4.4%)
|
201.33M
est: 241.99M (-16.8%)
|
253.49M
est: 249.66M (+1.5%)
|
239.14M
est: 291.75M (-18.0%)
|
296.94M
est: 346.08M (-14.2%)
|
283.94M
est: 316.09M (-10.2%)
|
424.37M
est: 429.33M (-1.2%)
|
370.77M
370.77M – 370.77M
-13.6% YoY
|
441.86M
441.86M – 441.86M
+19.2% YoY
|
529.61M
529.61M – 529.61M
+19.9% YoY
|
| EPS |
0.08
est: 0.11 (-22.4%)
|
0.13
est: 0.15 (-13.3%)
|
0.20
est: 0.20 (+2.6%)
|
0.28
est: 0.28 (+0.0%)
|
0.31
est: 0.34 (-7.5%)
|
0.41
est: 0.42 (-2.4%)
|
0.34
est: 0.35 (-2.9%)
|
0.27
est: 0.41 (-34.1%)
|
0.27
est: 0.47 (-42.6%)
|
0.22
|
-0.32
est: 0.04 (-1,014.3%)
|
0.04
0.04 – 0.04
+14.3% YoY
|
0.07
0.07 – 0.07
+75.0% YoY
|
0.10
0.10 – 0.10
+42.9% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-26 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-25 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-19 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-18 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-15 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-14 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-13 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-12 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-11 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-08 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-07 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-06 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-30 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-29 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-28 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-27 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-530.43M
OE per share TTM
-0.76
Owner's Yield
-6.00%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
17.9%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 18 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 320.9K | 0.06% |
| 2 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.00% | 6.0K | 0.44% |
| 3 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 75.1K | 0.29% |
| 4 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 22.9K | 0.26% |
| 5 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 10.2K | 0.48% |
| 6 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 1.13M | 0.06% |
| 7 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 50.4K | 0.39% |
| 8 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 32.2K | 0.28% |
| 9 | Vanguard Total International Stock ETF VXUS | 0.00% | 1.57M | 0.05% |
| 10 | Vanguard ESG International Stock ETF VSGX | 0.00% | 9.9K | 0.10% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
-350.1K
Shares Outstanding
703.06M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jiaxiang Huang | Vice President | — | male |
| Jinsong Song | President & Director | — | male |
| Xiaoquan Jing | Vice President & Chief Financial Officer | — | male |
| Yunbin Ou | Company Secretary & Head of Investor Relations | — | female |
| Zheng Yang | Accounting Supervisor | — | — |
| Zhilin Ren | Supervisor | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 600055.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
